Dr. Agarwal's Eye Hospital Limited (BOM:526783)
India · Delayed Price · Currency is INR 5,045.30
+40.45 (0.81%)
At close: Jun 22, 2026
BOM:526783 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 701 | 546.5 | 463.6 | 369.2 | 241 |
Depreciation & Amortization | 456.4 | 393.9 | 265.2 | 199.2 | 199.6 |
Other Amortization | - | 0.6 | 0.9 | 2.6 | 4.3 |
Loss (Gain) From Sale of Assets | - | 1.6 | 2.3 | -0.3 | -2.2 |
Loss (Gain) From Sale of Investments | -27.7 | - | - | - | - |
Provision & Write-off of Bad Debts | 13.3 | 3.9 | 8.6 | 8 | 13.2 |
Other Operating Activities | 247.1 | 59.2 | 57.3 | 68.1 | 49.7 |
Change in Accounts Receivable | -60.7 | -14.6 | -37.1 | -19.8 | -12.2 |
Change in Inventory | -7 | -36.5 | -37.5 | -2.7 | -5.1 |
Change in Accounts Payable | - | -0.5 | 68.6 | 10.3 | 83.4 |
Change in Other Net Operating Assets | 129 | -9.3 | 105.8 | 61.6 | -4.9 |
Operating Cash Flow | 1,451 | 944.8 | 897.7 | 696.2 | 566.8 |
Operating Cash Flow Growth | 53.62% | 5.25% | 28.94% | 22.83% | 67.33% |
Capital Expenditures | -983.9 | -1,029 | -713.2 | -703.4 | -467.3 |
Sale of Property, Plant & Equipment | 5.5 | 4.1 | 10 | 0.7 | 3.2 |
Cash Acquisitions | -23 | -184.8 | -5 | - | - |
Investment in Securities | -736.6 | -117.5 | - | - | - |
Other Investing Activities | 2.7 | -1 | 7.8 | -3.4 | 1.3 |
Investing Cash Flow | -1,735 | -1,328 | -700.4 | -706.1 | -462.8 |
Short-Term Debt Issued | - | - | - | - | 30 |
Long-Term Debt Issued | - | 561.8 | 150 | 209.4 | 257.5 |
Total Debt Issued | - | 561.8 | 150 | 209.4 | 287.5 |
Short-Term Debt Repaid | - | - | - | - | -38.7 |
Long-Term Debt Repaid | -404.9 | -340.7 | -264.2 | -174.9 | -268.8 |
Total Debt Repaid | -404.9 | -340.7 | -264.2 | -174.9 | -307.5 |
Net Debt Issued (Repaid) | -404.9 | 221.1 | -114.2 | 34.5 | -20 |
Issuance of Common Stock | 696.6 | - | - | - | - |
Common Dividends Paid | -30.9 | -23.5 | -25.8 | -14.1 | -0.2 |
Other Financing Activities | -13 | -31.8 | -2.3 | -17.8 | -17.9 |
Financing Cash Flow | 247.8 | 165.8 | -142.3 | 2.6 | -38.1 |
Net Cash Flow | -36.1 | -217.2 | 55 | -7.3 | 65.9 |
Free Cash Flow | 467.5 | -83.8 | 184.5 | -7.2 | 99.5 |
Free Cash Flow Growth | - | - | - | - | -56.15% |
Free Cash Flow Margin | 9.93% | -2.11% | 5.78% | -0.27% | 4.95% |
Free Cash Flow Per Share | 98.05 | -17.83 | 39.26 | -1.53 | 21.17 |
Cash Interest Paid | 13 | 31.8 | 2.3 | 17.8 | 17.9 |
Cash Income Tax Paid | 90.4 | 201.3 | 136.1 | 115.2 | 89.3 |
Levered Free Cash Flow | 152.03 | -249.69 | 104.08 | -171.21 | 12.45 |
Unlevered Free Cash Flow | 226.34 | -172.44 | 148.45 | -128.71 | 50.7 |
Change in Working Capital | 61.3 | -60.9 | 99.8 | 49.4 | 61.2 |